Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T17:56:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision version updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T14:28:59.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The history adds a new revision entry (v3.4.2) and removes the previous notices (v3.4.1). There are no changes to the study details or results.
    Difference
    1.0%
    Check dated 2026-02-11T01:58:03.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status was added to the page. The record version was updated from v3.4.0 to v3.4.1.
    Difference
    1.0%
    Check dated 2026-02-03T23:24:10.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The update adds UI elements for the record history, including a glossary toggle, color-coded change highlights (green for additions and red crossed-out for deletions), and a new revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T21:06:52.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link from the footer, updating the page metadata; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-23T00:32:22.000Z thumbnail image

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.